1. Home
  2. ELVN vs ASTL Comparison

ELVN vs ASTL Comparison

Compare ELVN & ASTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • ASTL
  • Stock Information
  • Founded
  • ELVN 2016
  • ASTL 1902
  • Country
  • ELVN United States
  • ASTL Canada
  • Employees
  • ELVN N/A
  • ASTL N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • ASTL Steel/Iron Ore
  • Sector
  • ELVN Health Care
  • ASTL Industrials
  • Exchange
  • ELVN Nasdaq
  • ASTL Nasdaq
  • Market Cap
  • ELVN 1.3B
  • ASTL 1.1B
  • IPO Year
  • ELVN 2020
  • ASTL N/A
  • Fundamental
  • Price
  • ELVN $25.91
  • ASTL $11.32
  • Analyst Decision
  • ELVN Strong Buy
  • ASTL
  • Analyst Count
  • ELVN 4
  • ASTL 0
  • Target Price
  • ELVN $36.75
  • ASTL N/A
  • AVG Volume (30 Days)
  • ELVN 244.8K
  • ASTL 733.8K
  • Earning Date
  • ELVN 11-13-2024
  • ASTL 11-06-2024
  • Dividend Yield
  • ELVN N/A
  • ASTL 1.75%
  • EPS Growth
  • ELVN N/A
  • ASTL N/A
  • EPS
  • ELVN N/A
  • ASTL N/A
  • Revenue
  • ELVN N/A
  • ASTL $1,840,778,711.00
  • Revenue This Year
  • ELVN N/A
  • ASTL N/A
  • Revenue Next Year
  • ELVN N/A
  • ASTL $15.80
  • P/E Ratio
  • ELVN N/A
  • ASTL N/A
  • Revenue Growth
  • ELVN N/A
  • ASTL N/A
  • 52 Week Low
  • ELVN $9.80
  • ASTL $6.67
  • 52 Week High
  • ELVN $30.03
  • ASTL $12.14
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 41.12
  • ASTL 59.91
  • Support Level
  • ELVN $24.69
  • ASTL $10.76
  • Resistance Level
  • ELVN $26.48
  • ASTL $11.69
  • Average True Range (ATR)
  • ELVN 1.38
  • ASTL 0.48
  • MACD
  • ELVN -0.32
  • ASTL -0.00
  • Stochastic Oscillator
  • ELVN 28.35
  • ASTL 56.86

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.

About ASTL Algoma Steel Group Inc.

Algoma Steel Group Inc is a Canadian company engaged in the production of clean and consistent light gauge steel. The company offers a range of hot and cold rolled steel sheet and plate products. The firm operates in a single segment of basic steel production including sheets, plates, slabs, and freights. The company's revenue is generated from contracts to produce, ship, and deliver steel products Geographically it serves Canada, the United States, and the rest of the world, whilst driving key revenue from domestic sales. The company generates the majority of its revenue from the sale of Steel sheets and strips.

Share on Social Networks: